SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-177763
Filing Date
2020-06-24
Accepted
2020-06-24 17:08:10
Documents
16
Period of Report
2020-06-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d920891d8k.htm   iXBRL 8-K 60165
2 EX-2.1 d920891dex21.htm EX-2.1 603538
3 EX-10.1 d920891dex101.htm EX-10.1 341021
4 EX-10.2 d920891dex102.htm EX-10.2 58765
5 EX-10.3 d920891dex103.htm EX-10.3 107197
  Complete submission text file 0001193125-20-177763.txt   1542546

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nvta-20200621.xsd EX-101.SCH 3066
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvta-20200621_lab.xml EX-101.LAB 17373
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvta-20200621_pre.xml EX-101.PRE 10950
11 EXTRACTED XBRL INSTANCE DOCUMENT d920891d8k_htm.xml XML 3272
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 20986341
SIC: 8071 Services-Medical Laboratories